Pioglitazone is a medication commonly prescribed to treat type 2 diabetes in adults. It is a form of thiazolidinedione, which works to lower and control blood sugar by improving insulin sensitivity. The medicine comes in tablet form and is typically taken once a day. Common side effects of pioglitazone may include muscle pain, fluid retention, and headache.
Pioglitazone is manufactured by Takeda Pharmaceutical Company.
How Does Pioglitazone Work?
Pioglitazone is part of a group of diabetes medications called thiazolidinediones (or sometimes called "glitazones"). The medication helps to improve insulin sensitivity, meaning that it helps your body use its natural insulin better. This helps to lower blood sugar and keep it under better control.
Effects of Pioglitazone
There have been several studies looking at the effects of pioglitazone on type 2 diabetes.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 24, 2012.
Watson Pharmaceuticals, Inc. Watson announces Actos(R) patent challenge settlement (3/10/2010). Watson Web site. Available at: http://ir.watson.com/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=1401044. Accessed April 1, 2010.
Ranbaxy Pharmaceuticals, Inc. Ranbaxy announces settlement of Actos (pioglitazone hydrochloride) patent litigation (3/15/2010). Ranbaxy Web site. Available at: http://www.ranbaxy.com/news/newsdisp.aspx?cp=956&flag=LN. Accessed April 1, 2010.
Mylan, Inc. Mylan announces first-to-file opportunity settlement agreements for Actoplus Met(R) and Actos(R) (3/16/2010). Mylan Web site. Available at: http://investor.mylan.com/releasedetail.cfm?ReleaseID=452248. Accessed April 1, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click